Many of the trials delivered at the CRF are run in collaboration with commercial companies who are developing new treatments or testing new devices. Some of these trials are co-funded by medical research charities and by the Government.
We collaborate with some of the world’s largest pharmaceutical companies, such as AstraZeneca, GlaxoSmithKline and Roche and also work with specialist small to medium-sized enterprises (SMEs), such as E-therapeutics, Oncolytics and Transgene.
The patient pool we can recruit from is extensive. Leeds Teaching Hospitals is one of the largest NHS Trusts in the country, providing specialist care for up to 5.4 million people in Yorkshire and Humberside, drawn from a region that is ethnically and geographically diverse.
The strong partnership between Leeds Teaching Hospitals and the University of Leeds jointly represents a vast wealth of resources - financial, infrastructure, people and methodologies – that companies working with us can draw on. This spans the entire medical pipeline from discovery science through to widespread and routine implementation at patient and practitioner level. The clinical and academic resources underpinning our facility ensures we provide an exceptionally high quality of data from our trials. Additional expertise we draw on includes the Leeds Clinical Trials Research Unit , the Haematological Malignancies Diagnostics Service, the Leeds Biobanking and Sample Processing Facility and phenotyping expertise within the NIHR Leeds Musculoskeletal Biomedical Research Unit.
To talk to us about running your trial at NIHR Leeds CRF, contact:
Debbie Beirne CRF Manager – Deputy Director
Dr Richard Evans, Research & Innovation Manager for Performance & Industry, Leeds Teaching Hospitals
Tel 0113 2060494
About Dr Richard Evans:
Richard has worked in the NHS for over seven years, previously managing Pharmacy services to clinical trials at York Teaching Hospital NHS Foundation Trust. Richard holds a PhD in Chemical Engineering, a Postgraduate Certificate in Health Research (both from the University of Leeds) and a BSc (HONS) in Biochemistry with Biotechnology from the University of Manchester Institute of Science and Technology.